Search

Home

40 YEARS OF EXPERIENCE

Neuraxpharm,
your CNS specialist

Finding solutions for disorders related to the central nervous system.

Scroll to explore

CNS: Our focus at Neuraxpharm

Addressing a wide variety of CNS disorders to bring treatments to patients in need

Discover more

Innovation: Transforming CNS care

Providing innovative solutions with the goal of improving quality of life for CNS patients

Learn more

Driving change

Neuraxpharm
Commitment

Know more about Neuraxpharm

1 in 4 people in the world will be affected by mental or neurological disorders at some point in their lives. This equates to nearly every family having at least one afflicted person in the home.

As a leading European pharmaceutical company specialized in the treatment of central nervous system (CNS) disorders, Neuraxpharm is committed to addressing the unmet needs of patients with psychiatric and neurological conditions.

Our purpose is to offer a comprehensive and specialized range of CNS therapeutic solutions to improve the daily lives of patients across Europe and beyond. 

For doctors, pharmacists, caretakers, patients and their families, we are your expert CNS specialist.

Focusing on the early detection, prevention and treatment of chronic, severe and standard CNS disorders

Key research areas

Alzheimer's

Anxiety

Chronic pain

Depression

Epilepsy

Multiple Sclerosis

Parkinson's

Psychosis / Schizophrenia

See all CNS disorders

Innovation

Visit our section on Innovation to see how we are addressing the unmet needs of CNS patients

Go to Innovation

Neuraxpharm
News

As experts in CNS disorders, we bring you the latest news, product launches and innovative initiatives we constantly undertake to always stay ahead of developments in the CNS area.

Neuraxpharm continues to shine a light on the need for improved epilepsy management

ACT FAST, STOP SEIZURES, SAVE LIVES is a campaign aimed at educating and empowering epilepsy patients, their caregivers and healthcare professionals to respond effectively to seizure emergencies.
Neuraxpharm

Reflecting on Neuraxpharm’s journey in CNS care and innovation: a video

We are proud to share an overview of our mission and our dedication to improving the lives of patients affected by neurological and psychiatric disorders.
CMO Nx

Neuraxpharm appoints Vikas Mohan Sharma as Chief Medical Officer

Vikas brings over 25 years of healthcare and clinical research experience leading high-value clinical & medical scientific teams across multiple therapeutic areas to deliver successful developmental and program milestones in large pharma and Clinical Research

Neuraxpharm Pharmaceuticals awarded EcoVadis Silver Medal for sustainability

Neuraxpharm Pharmaceuticals has once again received a Silver Medal from EcoVadis, placing us among the top 15% of companies assessed globally for sustainability management performance.

Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies

New therapies will allow patients greater choice and flexibility in the control of CNS disorders

Neuraxpharm reports another year of sustained growth and international expansion

CNS specialist continues growth strategy across Europe and beyond, optimizing commercial efficiency and maintaining strong focus on innovation

Neuraxpharm Blog

Understand more about psychiatric and neurological disorders. Our team of health care professionals and expert journalists across Europe works to consistently bring you scientifically solid, trustable information to answer your concerns.

Chronic pain

What are the differences between Acute and Chronic Pain

Pain is a complex phenomenon to study, understand and treat. It is a personal experience with a multidimensional character influenced by biological, psychological and social factors. There is a misconception that the difference between acute and chronic pain. When considering pain and time, we could say that there are three types of pain: acute pain, persistent pain and chronic pain.

Read more

Alzheimer's

Is Alzheimer’s hereditary?

In 95% of cases, Alzheimer’s disease is the result of a combination of genetic, environmental and lifestyle factors that affect the person…

Alzheimer's

10 first symptoms of Alzheimer’s

Alzheimer’s disease has many faces. Depending on the region that is affected, the symptoms will vary. Just as the manifestation of the…
Treating Cognitive Impairment in Multiple Sclerosis

Multiple sclerosis

Cognitive impairment in Multiple Sclerosis: a reality to treat as early as possible

Cognitive impairment has been reported at all phases and all subtypes of multiple sclerosis (MS). The severity and type of cognitive impairment…

CNS

Neuraxpharm

Support

Linkedin Youtube

Join our mailing list

Get the latest updates from the Neuraxpharm.